Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.
Deutsche Bank on Medical Supply & Device Stocks: J&J (NYSE: JNJ) Exiting Stents; First in, First Out
-
Notable Analyst Rating Changes 09/10: MCO, NOK, CCE, ALL Upgraded; DELL, CSCO, ADBE, SFD Downgraded
-
Deutsche Bank Initiates Coverage on Covidien Ltd (COV) with a Buy; Near-Term Challenges, Longer Term Value
-
Deutsche Bank Cautiously Starts Coverage on MedTech Stocks, Sees Challenges Ahead; BAX, MDT, COV Named Top Picks
-
Notable 52-Week High's and Low's of the Day 07/29: CTXS, ENTR, CROX, VMED High; NVDA, SYMC, LSI, COV Low
-
Deutsche Bank maintains a 'Hold' on Aspect Medical Systems (ASPM); Raises PT on Covidien (COV) Acquisition Announcement
-
Morning Movers 5/8: FTWR, RDNT, VNUS, AXL, FITB, LEAP Higher; DPTR, CROX, INAP, HUN, GNW Lower
-
Covidien (COV) Sees Pressure On Move to Re-Incorporate In Ireland
-
David Moenning's Daily State of the Markets: 10/13
-
Deutsche Bank Upgrades Covidien, Ltd. (COV) to Buy
